Cyprus vs Senegal: Hepatitis B surface antigen (HBsAg) prevalence
Cyprus
0.5%
in 2024
Senegal
0.4%
in 2024
Cyprus rank
59th
Senegal rank
62nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cyprus
- Senegal
How they compare
Cyprus currently reports 0.5% against 0.4% in Senegal, a difference of 0.1%.
That makes Cyprus's figure about 1.2 times Senegal's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Senegal ahead.
Cyprus ranks 59th and Senegal ranks 62nd of 194 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.8% | 0.2% | Senegal |
| 2020s | 0.5% | 0.5% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cyprus or Senegal?
- Cyprus, at 0.5% against 0.4% in Senegal as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cyprus and Senegal?
- 0.1%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Cyprus and Senegal rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cyprus ranks 59th and Senegal ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.